Skip to main content
. 2017 Nov 7;20(2):166–172. doi: 10.4103/aja.aja_49_17

Figure 1.

Figure 1

Treatment of LXA4 improves erectile dysfunction elicited by electrical stimulation of the cavernous nerve. (a) Representative ICP tracings were measured through stimulation of 2.5 and 5 V for 1 min, respectively. Ratios of max ICP and AUC to MAP of all the three groups were presented through bar graphs: (b) for max ICP/MAP and (c) for AUC/MAP. Data are expressed as mean ± s.e.m. (ncontrol = 10, nDMED = 11, and nDMED + LXA4 = 11). **P < 0.01 and ***P < 0.001 when comparing two groups. DMED: diabetes mellitus-induced erectile dysfunction; LXA4: Lipoxin A4; ICP: intracavernous pressure; AUC: area under the curve; MAP: mean arterial pressure. Scale bars = 1 min; s.e.m.: standard error of the mean.